These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Kinetic Studies of Ammonia Monooxygenase Inhibition in Nitrosomonas europaea by Hydrocarbons and Halogenated Hydrocarbons in an Optimized Whole-Cell Assay.
    Author: Keener WK, Arp DJ.
    Journal: Appl Environ Microbiol; 1993 Aug; 59(8):2501-10. PubMed ID: 16349014.
    Abstract:
    The inhibitory effects of 15 hydrocarbons and halogenated hydrocarbons on NH(3) oxidation by ammonia monooxygenase (AMO) in intact cells of the nitrifying bacterium Nitrosomonas europaea were determined. Determination of AMO activity, measured as NO(2) production, required coupling of hydroxylamine oxidoreductase (HAO) activity with NH(3)-dependent NH(2)OH production by AMO. Hydrazine, an alternate substrate for HAO, was added to the reaction mixtures as a source of reductant for AMO. Most inhibitors exhibited competitive or noncompetitive inhibition patterns. The competitive character generally decreased (K(i) (E)/K(i) (ES) increased) as the molecular size of the inhibitors increased. For example, CH(4) and C(2)H(4) were competitive inhibitors of NH(3) oxidation, whereas the remaining alkanes (up to C(4)) and monohalogenated (Cl, Br, I) alkanes were noncompetitive. Oxidation of C(2)H(5)Br (noncompetitive) increased as the NH(4) concentration increased up to 40 mM, whereas oxidations of inhibitors with competitive character (K(i) (E) << K(i) (ES)) were diminished at 40 mM NH(4). Multichlorinated compounds produced nonlinear Lineweaver-Burk plots. Iodinated alkanes (CH(3)I, C(2)H(5)I) and C(2)Cl(4) were potent inhibitors of NH(3) oxidation. Maximum rates of NH(3), C(2)H(4), and C(2)H(6) oxidations were approximately equivalent, suggesting a common rate-determining step. These data support an active-site model for AMO consisting of an NH(3)-binding site and a second site that binds noncompetitive inhibitors, with oxidation occurring at either site.
    [Abstract] [Full Text] [Related] [New Search]